Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Stranica 1 iz 33 rezultatima
Methods for treatment of kallikrein-related disorders
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
BACKGROUND OF THE INVENTION
The invention relates to methods for treating plasma kallikrein-related disorders, such as diseases or conditions associated with increased vascular permeability or astrocyte activation. Such diseases include diabetic retinopathy, macular edema, intracerebral hemorrhage,
Prodrug salts
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
TECHNICAL FIELD
Provided are novel prodrug salts of selective aquaporin inhibitors, e.g., of aquaporin-4 and/or aquaporin-2, of Formula I as described below, their use as pharmaceuticals and pharmaceutical compositions comprising them, and novel intermediates used in and novel processes for their
Prodrug salts
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
TECHNICAL FIELD
Provided are novel prodrug salts of selective aquaporin inhibitors, e.g., of aquaporin-4 and/or aquaporin-2, of Formula I as described below, their use as pharmaceuticals and pharmaceutical compositions comprising them, and novel intermediates used in and novel processes for their
Method of treating migraine headache without aura
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
TECHNICAL FIELD OF THE INVENTION
The present invention relates to methods and compositions for treating selected conditions of the central and peripheral nervous systems employing non-synaptic mechanisms. More specifically, one aspect of the present invention relates to methods and compositions for
Methods and compositions for treating conditions of the central and peripheral nervous systems using non-synaptic mechanisms
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
TECHNICAL FIELD OF THE INVENTION
The present invention relates to methods and compositions for treating selected conditions of the central and peripheral nervous systems employing non-synaptic mechanisms. More specifically, one aspect of the present invention relates to methods and materials for
Triaza-cyclopenta[cd]indene derivatives
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
This Application is a 371 of PCT/JP2005/000323, filed Jan. 6, 2005; the disclosure of which is incorporated herein by reference.
DETAILED DESCRIPTION OF THE INVENTION
1. Technical Field
The present invention relates to a therapeutic agent for diseases in which corticotropin releasing factor (CRF) is
Pyrrolopyrimidine and pyrrolotriazine derivatives
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
This Application is a 371 of PCT/JP2005/000319, filed Jan. 6, 2005.
DETAILED DESCRIPTION OF THE INVENTION
1. Technical Field
The present invention relates to a therapeutic agent for diseases in which corticotropin releasing factor (CRF) is considered to be involved, such as depression, anxiety,
Substituted thieno[3,2-d]pyrimidines as CRF receptor antagonists
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
This Application is a 371 of PCT/JP2005/000318, filed Jan. 6, 2005; the disclosure of which is incorporated herein by reference.
DETAILED DESCRIPTION OF THE INVENTION
1. Technical Field
The present invention relates to a therapeutic agent for diseases in which corticotropin releasing factor (CRF) is
Pyrrolopyridine derivatives substituted with cyclic amino group
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
DETAILED DESCRIPTION OF THE INVENTION
1. Technical Field
The present invention relates to a therapeutic agent for diseases in which corticotropin releasing factor (CRF) is considered to be involved, such as depression, anxiety, Alzheimer's disease, Parkinson's disease, Huntington's chorea, eating
Pyrrolo[2,3-d]pyrimidine derivatives substituted with a cyclic amino group
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
DETAILED DESCRIPTION OF THE INVENTION
1. Technical Field
The present invention relates to a therapeutic agent for diseases in which corticotropin releasing factor (CRF) is considered to be involved, such as depression, anxiety, Alzheimer's disease, Parkinson's disease, Huntington's chorea, eating
Prodrug amino acid derivative
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
TECHNICAL FIELD
The present invention relates to prodrugs of (1R,2R,3R,5R,6R)-2-amino-6-fluoro-3-alkoxybicyclo[3.1.0]hexane-2,6-dicarb- oxylic acid derivatives and (1S,2R,3R,5R,6S)-2-amino-3-alkoxybicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives useful as drugs. More specifically, the present
Prodrug of amino acid derivative
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
CROSS-REFERENCE TO RELATED PATENT APPLICATIONS
This application is a National Stage Entry of International Application No. PCT/JP2017/016125, filed Apr. 18, 2017, which claims priority from Japanese Patent Application No. 2016-083147, filed Apr. 18, 2016. The entire contents of the above-referenced
Bumetanide analogs, compositions and methods of use
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
FIELD OF THE INVENTION
The present invention relates to bumetanide, furosemide, piretanide, azosemide, and torsemide analogs, including derivatives, positional isomers, and prodrugs thereof, compositions comprising the same and methods of making and using the same. The present invention also relates
.beta.- and .gamma.-diketones and .gamma.-hydroxyketones as WNT/ .beta.-catenin signaling pathway activators
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to activators of one or more proteins in the Wnt pathway, including activators of one or more Wnt proteins, and compositions comprising the same. More particularly, it concerns the use of a .beta.-diketone, .gamma.-diketone
.beta.- and .gamma.-diketones and .gamma.-hydroxyketones as WNT/ .beta.-catenin signaling pathway activators
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to activators of one or more proteins in the Wnt pathway, including activators of one or more Wnt proteins, and compositions comprising the same. More particularly, it concerns the use of a .beta.-diketone, .gamma.-diketone
Najkompletnija baza ljekovitog bilja potpomognuta znanošću
- Radi na 55 jezika
- Biljni lijekovi potpomognuti znanošću
- Prepoznavanje bilja slikom
- Interaktivna GPS karta - označite bilje na mjestu (uskoro)
- Pročitajte znanstvene publikacije povezane s vašom pretragom
- Pretražite ljekovito bilje po učincima
- Organizirajte svoje interese i budite u toku s istraživanjem vijesti, kliničkim ispitivanjima i patentima
Upišite simptom ili bolest i pročitajte o biljkama koje bi mogle pomoći, unesite travu i pogledajte bolesti i simptome protiv kojih se koristi.
* Svi podaci temelje se na objavljenim znanstvenim istraživanjima
